Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors.
Ykema B, Rigter L, Spaander M, Moons L, Bisseling T, Aleman B, de Boer JP, Lugtenburg P, Janus C, Petersen E, Roesink J, Raemaekers J, van der Maazen R, Lansdorp-Vogelaar I, Gini A, Verbeek W, Lemmens M, Meijer G, van Leeuwen F, Snaebjornsson P, Carvalho B, van Leerdam M. Ykema B, et al. Among authors: verbeek w. J Clin Med. 2020 Jan 10;9(1):190. doi: 10.3390/jcm9010190. J Clin Med. 2020. PMID: 31936745 Free PMC article.
Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.
Ykema BLM, Rigter LS, Spaander MCW, Moons LMG, Bisseling TM, Aleman BMP, Dekker E, Verbeek WHM, Kuipers EJ, de Boer JP, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Meijer GA, Schaapveld M, van Leeuwen FE, Carvalho B, Snaebjornsson P, van Leerdam ME. Ykema BLM, et al. Among authors: verbeek whm. Dig Endosc. 2022 Jan;34(1):163-170. doi: 10.1111/den.14004. Epub 2021 Jun 8. Dig Endosc. 2022. PMID: 33928678 Free PMC article.
Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.
Ykema BLM, Gini A, Rigter LS, Spaander MCW, Moons LMG, Bisseling TM, de Boer JP, Verbeek WHM, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM; DICHOS study group; Aleman BMP, Meijer GA, van Leeuwen FE, Snaebjornsson P, Carvalho B, van Leerdam ME, Lansdorp-Vogelaar I. Ykema BLM, et al. Among authors: verbeek whm. Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2157-2168. doi: 10.1158/1055-9965.EPI-22-0019. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36166472 Free PMC article.
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, Lopez-Yurda M, Grootscholten C, Beets GL, Snaebjornsson P, Maas M, Mertz M, Veninga V, Bounova G, Broeks A, Beets-Tan RG, de Wijkerslooth TR, van Lent AU, Marsman HA, Nuijten E, Kok NF, Kuiper M, Verbeek WH, Kok M, Van Leerdam ME, Schumacher TN, Voest EE, Haanen JB. Chalabi M, et al. Nat Med. 2020 Apr;26(4):566-576. doi: 10.1038/s41591-020-0805-8. Epub 2020 Apr 6. Nat Med. 2020. PMID: 32251400 Clinical Trial.
The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM, Verbeek WH, Zhernakova A, Onland-Moret C, Schreurs MW, Monsuur AJ, Verduijn W, Wijmenga C, Mulder CJ. Wolters VM, et al. Among authors: verbeek wh. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1399-405, 1405.e1-2. doi: 10.1016/j.cgh.2007.08.018. Epub 2007 Oct 29. Clin Gastroenterol Hepatol. 2007. PMID: 17967566
99 results